Table V.
Authors | Year | Technique | No. of hips | Mean age (year) | Duration of follow-up (year) | Survival rate (%) (THA as endpoint) | Survival rate (%) (poor results as an endpoint) | Follow-up rate (%) |
---|---|---|---|---|---|---|---|---|
White et al. [65] | 1980 | Shelf | 29 | 7 | 22 (10–31) | 43 | 57 at 25 years | N/A |
Fawzy et al. [66] | 2005 | Shelf | 76 | 33 (17–60) | 11 (6–14) | 46 | 86 at 5 years, 46 at 10 years | 100 |
Miguad et al. [67] | 2004 | Shelf | 56 | 32 (17–56) | 15 (15–30) | 58 | 37 at 20 years, | 93 |
Bickel and Breivis [68] | 1975 | Shelf | 141 | N/A | 12.8 (1–32) | 94 | 78 | 84 |
Saito et al. [70] | 1986 | Shelf | 27 | 25 (11–55) | 12 (5–19) | 92 | 93 | 77 |
Summers et al. [71] | 1988 | Shelf | 35 | 14 (3–41) | 16 (8–30) | 92 | 67 | 77 |
Love et al. [69] | 1980 | Shelf | 45 | 12 (6–22) | 11 (2–20) | 88 | 84 | 80 |
Nishimatsu et al. [73] | 2002 | Shelf | 106 | 25 | 23.8 (15–41) | 89 | 70 | 64 |
Hirose et al. [63] | 2011 | Shelf | 28 | 34 (17–54) | 25 (20–32) | 80 | 78 at 10 years, 53 at 15 years | 49 |
Bartonicek et al. [72] | 2012 | Shelf | 25 | 31 (16–52) | 15 (10–23) | 80 | 80 | 100 |